Pain: Clinical Trials

1,278 trials for Pain, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1278 completed. 1278 Phase 2, 185 Phase 3, 149 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 21278Completed 1278
Phase 3185Completed 185
Phase 1149Completed 149

Follow Pain: new trials by email Literature Review of Pain trials Research Report on Pain

Trials (filtered) newest first · largest first

All 1,278 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Use of Topical Ocular BL1332 for the Management of Postoperative Ocular Pain Following Photorefractive Keratectomy
Topical Ocular BL1332 low dose, Topical Ocular BL1332 high dose, BL1332 Vehicle ophthalmic vehicle - Pain, Postoperative
Phase 2CompletedBausch & Lomb Incorporated1302026-03-312026-10-22
A Randomized Comparison Between 0.67 mcg/kg, 1 mcg/kg, and 1.33 mcg/kg of Perineural Dexmedetomidine for Ultrasound-Guided Infraclavicular Block
dexmedetomidine (perineural) 0.67 mcg/kg, dexmedetomidine (perineural) 1 mcg/kg, dexmedetomidine (perineural) 1.33 mcg/kg - Analgesia, Pain, Acute
Phase 2CompletedMcGill University Health Centre/Research Institute of the McGill University Health Centre692025-12-282026-07-07
Intranasal and Intravenous Oxytocin for Analgesia to Noxious Heat Pain
Intravenous oxytocin, Intravenous placebo, Intranasal oxytocin - Pain, Acute
Phase 2CompletedWake Forest University Health Sciences242025-11-052026-06-30
An Efficacy and Safety Study of LTG-001 Following Abdominoplasty
Experimental: LTG-001 High Dose, Experimental: LTG-001 Low Dose, Active Comparator: HB/APAP - Acute Pain, Postoperative Pain Control
Phase 2CompletedLatigo Biotherapeutics3432025-07-242026-04-29
Opiranserin Injections PCA Regimens for Postoperative Pain
VVZ-149 Injections, Fentanyl - Pain, Postoperative / Acute Pain
Phase 2CompletedSamsung Medical Center662025-07-222026-09-15
Effects of CBD/CBD-A Oral Extract on Resting-state EEG and Neuropathic Pain Symptoms After SCI
CBD/CBD-A, Placebo - SCI - Spinal Cord Injury, Neuropathic Pain
Phase 1 / Phase 2CompletedUniversity of Miami62025-06-162026-08-14
Unique Treatment of Oncology Pain in Advanced Cancer
Trichomylin® capsule (5 mg delta-9-tetrahydrocannabinol: 5 mg cannabidiol: 5 mg cannabichromene) - Cancer Pain
Phase 2CompletedZYUS Life Sciences Inc.112025-06-122026-09-01
A Study of YZJ-4729 Tartrate Injection for the Treatment of Pain After Orthopedic Surgery
YZJ-4729, Placebo Comparator: Saline, Active Comparator: Morphine - Pain
Phase 2CompletedShanghai Haiyan Pharmaceutical Technology Co., Ltd.1502025-05-232026-06-29
Ultrasound Guided Lumbar Erector Spinae Block Using Bupivacaine - Magnesium Sulphate Versus Bupivacaine - Dexamethasone in Total Hip Replacement Surgery
Bupivacaine-Magnesium Sulphate, Bupivacaine-Dexamethasone, Bupivacaine-Saline - Post-operative Pain, Total Hip Arthroplasty (THA)
Phase 2CompletedAin Shams University662025-05-012026-02-18
Impact of Cannabinoids on Menopause Symptoms
Active Cannabinoid Product, Placebo - Perimenopause, Menopause
Phase 2CompletedWashington State University1042025-03-032026-06-02
Safety and Efficacy Trial of MTX101 2mg for the Acute Treatment of Migraine in Adults
MTX101, Placebo - Migraine
Phase 2CompletedManistee Therapeutics782025-02-242025-10-07
A Study of ONO-1110 in Patients With Postherpetic Neuralgia
ONO-1110, Placebo - Postherpetic Neuralgia
Phase 2CompletedOno Pharmaceutical Co., Ltd.1422025-02-122026-07-15
The Impact of Vericiguat on Microvascular Function in Patients With Documented Vasospastic Angina Pectoris
Vericiguat - Vasospastic Angina
Phase 2CompletedAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)572025-02-102026-07-29
Phase 2B Study Assessing Pain Relief After Replacement of the Knee
ATX101, bupivacaine hydrochloride, saline placebo - Total Knee Arthroplasty (Postoperative Pain)
Phase 2CompletedAllay Therapeutics, Inc.2262025-02-032026-10-19
A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adult Subjects With Idiopathic Gastroparesis.
CIN-102 Dose 15mg, Placebo, CIN-102 Dose 10mg - Idiopathic Gastroparesis
Phase 2CompletedCinDome Pharma, Inc.4162025-01-292026-07-13
Krill Oil for Pain in Elders
Krill oil, Mixed vegetable oil - Chronic Musculoskeletal Pain
Phase 2CompletedUniversity of Florida402025-01-172026-06-17
Effect of Magnesium Sulfate on Hemodynamics on Laparoscopic Cholecystectomy Patients
Placebo, Magnesium - Hemodynamics Instability, Pain After Surgery
Phase 1 / Phase 2CompletedZiauddin University602025-01-062026-09-02
This is a Study Evaluating the Efficacy and Safety of LTG-001 for Acute Pain After Surgical Removal of Impacted Third Molars
LTG-001 High Dose, LTG-001 Mid Dose, LTG-001 Low Dose - Acute Pain, Postoperative
Phase 2CompletedLatigo Biotherapeutics2502024-12-192026-05-22
A Randomized Controlled Trial to Test the Effects Oxytocin and Vibration Have on Heat Pain Threshold After UV-B Burn
oxytocin, placebo - Sunburn
Phase 2CompletedWake Forest University Health Sciences382024-12-052026-01-12
A Study Evaluating Efficacy and Safety of VX-993 for Acute Pain After a Bunionectomy
VX-993, HB/APAP, Placebo (matched to VX-993) - Acute Pain
Phase 2CompletedVertex Pharmaceuticals Incorporated3672024-10-292026-05-28

Showing 20 of 1278. Sign in to see all of them.

Narrower conditions

Pain, Postoperative (246)  ·  Chronic Pain (101)  ·  Neuralgia (98)  ·  Agnosia (79)  ·  Low Back Pain (79)  ·  Acute Pain (76)  ·  Neuralgia, Postherpetic (48)  ·  Osteoarthritis (45)  ·  Headache (43)  ·  Back Pain (35)  ·  Abdominal Pain (34)  ·  Neoplasms (32)  ·  Migraine Disorders (30)  ·  Diabetic Neuropathies (27)

Broader conditions

Neurologic Manifestations (1278)  ·  Pathological Conditions, Signs and Symptoms (1278)  ·  Signs and Symptoms (1277)  ·  Nervous System Diseases (381)  ·  Pathologic Processes (371)  ·  Postoperative Complications (251)  ·  Neuromuscular Diseases (214)  ·  Musculoskeletal Diseases (167)  ·  Peripheral Nervous System Diseases (159)  ·  Joint Diseases (93)  ·  Neurobehavioral Manifestations (87)  ·  Perceptual Disorders (82)  ·  Rheumatic Diseases (81)  ·  Cardiovascular Diseases (75)

Interventions

Bupivacaine (59)  ·  Acetaminophen (44)  ·  Morphine (43)  ·  Lidocaine (41)  ·  Saline Solution (35)  ·  Ketamine (28)  ·  Ibuprofen (27)  ·  Sodium Chloride (25)  ·  Fentanyl (22)  ·  Pregabalin (21)  ·  Ropivacaine (17)  ·  Celecoxib (16)  ·  Dexmedetomidine (16)  ·  Naproxen (16)  ·  Oxycodone (16)

Sponsors

Assiut University (27)  ·  National Institute of Dental and Craniofacial Research (NIDCR) (16)  ·  Pfizer (15)  ·  Pacira Pharmaceuticals, Inc (14)  ·  Mayo Clinic (12)  ·  Cairo University (11)  ·  GlaxoSmithKline (10)  ·  Heron Therapeutics (10)  ·  Johns Hopkins University (10)  ·  AstraZeneca (9)  ·  Montefiore Medical Center (9)  ·  National Center for Complementary and Integrative Health (NCCIH) (9)  ·  University of Florida (8)  ·  AbbVie (prior sponsor, Abbott) (7)  ·  Abbott (7)

Countries

United States (639)  ·  Canada (86)  ·  Egypt (65)  ·  Germany (63)  ·  United Kingdom (55)  ·  France (49)  ·  Spain (49)  ·  Poland (41)  ·  Denmark (35)  ·  Czechia (29)  ·  Australia (28)  ·  Israel (25)  ·  Netherlands (25)  ·  Belgium (24)  ·  Italy (24)

Top investigators

David Prior (5)  ·  Hala S Abdel-Ghaffar, MD (5)  ·  Bror Jonzon (4)  ·  Gert Bronfort, DC, PhD (4)  ·  Andrew K Chang, MD (3)  ·  Aziz Shaibani, MD (3)  ·  Claudia Campbell, PhD (3)

Results publications

PMID 22900785, PMID 36729473, PMID 37523477, PMID 17877825, PMID 21079055, PMID 22212857, PMID 22510183, PMID 22792007, PMID 22795280, PMID 27720917, PMID 27747583, PMID 27893109, PMID 28159728, PMID 30737315, PMID 32871021, PMID 34532852, PMID 37530822, PMID 10353500, PMID 10613619, PMID 11145807, PMID 11323325, PMID 12145072, PMID 12148679, PMID 12384756, PMID 12779107, PMID 12807853, PMID 12897484, PMID 14665993, PMID 15115710, PMID 15230906, PMID 15454701, PMID 15556826, PMID 15560360, PMID 15616047, PMID 15680647, PMID 15798411, PMID 15834546, PMID 15943960, PMID 15963313, PMID 16192528, PMID 16275600, PMID 16371894, PMID 16436839, PMID 16698416, PMID 16959427, PMID 17174178, PMID 17320744, PMID 17342504, PMID 17414235, PMID 17437870

NIH funding

2008 (7), 2015 (5), 2018 (5), 2019 (5), 2009 (4), 2016 (4), 2014 (3), 2017 (3), 2023 (3), P30CA015083 (3), 2004 (2), 2005 (2), K23HL151880 (2), P01NS041386 (2), P01NS119159 (2)